Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3′ genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates-Reference-Cited by-同舟云学术

Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3′ genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates

Published:2007-08 Issue:34 Volume:25 Page:6409-6422
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Nolan Sheila M.,Skiadopoulos Mario H.,Bradley Konrad,Kim Olivia S.,Bier Stacia,Amaro-Carambot Emerito,Surman Sonja R.,Davis Stephanie,St. Claire Marisa,Elkins Randy,Collins Peter L.,Murphy Brian R.,Schaap-Nutt Anne

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference51 articles.

1. Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics;Knott;Pediatr Infect Dis J,1994

2. The role of parainfluenza viruses in inspiratory difficulties in children;Korppi;Acta Paediatr Scand,1988

3. The Tecumseh study of respiratory illness. V. Patterns of infection with the parainfluenzaviruses;Monto;Am J Epidemiol,1973

4. Epidemiology of acute lower respiratory disease in children;Glezen;N Engl J Med,1973

5. Human parainfluenza virus-associated hospitalizations among children less than 5 years of age in the United States;Counihan;Pediatr Infect Dis J,2001

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and Children;Journal of the Pediatric Infectious Diseases Society;2023-01-03

2. Parainfluenza Viruses;Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases;2015

3. Vero/BC-F: an efficient packaging cell line stably expressing F protein to generate single round-infectious human parainfluenza virus type 2 vector;Gene Therapy;2014-06-19

4. Live-Attenuated Respiratory Syncytial Virus Vaccines;Current Topics in Microbiology and Immunology;2013

5. Respiratory Syncytial Virus Modified by Deletions of the NS2 Gene and Amino Acid S1313 of the L Polymerase Protein Is a Temperature-Sensitive, Live-Attenuated Vaccine Candidate That Is Phenotypically Stable at Physiological Temperature;Journal of Virology;2012-12-12